Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Arblast USA

Explore full profile

Arblast USA signed a world wide agreement with Arblast to the transfer of Arblast patents,

Kobe, JapanFounded 2005
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Arblast USA and the history behind them.

About Arblast USA

ArBlast USA specializes in the development and manufacture of advanced cell processing systems and culture mediums, primarily for ophthalmologic and dental applications. Leveraging extensive know-how in cultured corneal epithelial cell sheets and bone formation materials, the company provides solutions that comply with Good Manufacturing Practices (GMP). ArBlast's flagship product, the M Stars Keratinocyte Growth Medium, is optimized for culturing epithelial cells from various tissues including cornea, conjunctiva, skin, and oral mucosa. The company is also engaged in research and development of scaffolds with the potential to enable the production of artificial organs. ArBlast serves research institutions, medical facilities, and biotech companies, operating in the highly specialized market of advanced medical research and treatment solutions. The business model revolves around the sale of proprietary culture mediums and cell processing systems, as well as licensing patented technologies. Revenue is generated through direct sales, partnerships, and licensing agreements.

Source: Dealroom company data

At a glance

Founded
2005
Headquarters
Kobe, Japan

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Investors

24 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A24 investors entered at this stage

  • Dai Nippon Printing
  • Mitsubishi UFJ Capital
  • Mitsui Sumitomo Insurance Company
  • Neostella Capital
  • Marubeni
  • Sumitomo Corporation of Americas
  • Espec
  • Gentosha
  • Summit Pharmaceuticals International
  • Miyano Medical Instruments
  • Kizuna Capital Partners
  • ITX Corporation
  • Japan Asia Investment
  • Ant Capital Partners
  • Mizuho Capital
  • Rohto Pharmaceutical
  • Shinkin Capital
  • AG Capital
  • Bio-sight Capital
  • EPS
  • JAFCO
  • MBL Venture Capital
  • Marusan Securities
  • Aozora Investment Management

Talent

Book a demo to see the people
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇯🇵 Japan · Kobe HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Arblast USA on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Arblast USA on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles